Company intelligence / Profile preview

Covetrus

Portland, Maine, United Statescovetrus.com ↗

Ownership: Public · CVET
Employees: ~5000
Development stage: Commercial

Overview

Covetrus delivers technology-enabled solutions—including practice management software, prescription management/e-commerce tools, compounding pharmacy services, and supply chain solutions—to improve clinical and financial outcomes for veterinary practices globally. The company does not conduct clinical trials but operates at commercial scale with a comprehensive portfolio of products/services.

Modalities: DeviceSmall molecule (pharmaceuticals)Biologic (compounded medications)
Industry: Veterinary

Partnerships

Epicur Pharma/Compounding partner for customized medications

Financials

Market cap: $0
Total revenue: $1.2B
Enterprise value: $962M

Beyond the preview

Go deeper on Covetrus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Covetrus.

Explore the full profile